Case report: Successful treatment with daratumumab for pure red cell aplasia in a patient with mixed lymphoid chimerism after ABO-mismatched stem cell transplant for sickle cell disease

Pure red cell aplasia (PRCA) is a serious complication after ABO-mismatched allogeneic hematopoietic stem cell transplantation (HSCT). Following HSCT, persistent anti-donor isohemagglutinins against donor ABO antigens are considered the immunological cause of PRCA. Patients with post-transplant PRCA...

Celý popis

Podrobná bibliografie

Hlavní autoři:	E. Dovern, B. J. Biemond, E. Nur
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2023-06-01
Edice:	Frontiers in Immunology
Témata:	sickle cell disease hematopoietic (stem) cell transplantation (HCST) pure red cell aplasia (PRCA) mixed chimerism daratumumab (DARA)
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1212007/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!